HOME >> BIOLOGY >> NEWS
Can the tonsils influence oral HIV transmission?

Bethesda, MD Current research demonstrates that the tonsils may possess the necessary factors to act as a transmission site for the spread of HIV. The related report by Moutsopoulos et al, Tonsil Epithelial Factors May Influence Oropharyngeal Human Immunodeficiency Virus Transmission, appears in the August issue of The American Journal of Pathology.

Human immunodeficiency virus (HIV) spreads mainly through sexual contact of mucosal surfaces, which the virus must cross to come in contact with underlying immune cells for infection to occur. While the oral mucosal surfaces are largely protected by their thickened exterior and the defensive proteins present in saliva, it is speculated that a low number of infections may occur via oral sexual contact. Researchers have questioned whether such transmission is facilitated by the tonsils, which contain high numbers of immune cells that may be easily accessible to HIV.

Researchers led by Dr. Sharon M. Wahl, of the National Institute of Dental and Craniofacial Research, NIH, examined this question by comparing the gene expression profiles of tonsils and oral gingiva. Although many of the genes examined showed similar expression patterns between the two oral sites, differences were observed. Notably, several genes related to immune functions, including HIV co-receptor CXCR4, displayed significantly higher expression in the tonsils while gingiva more strongly expressed keratin genes, which thicken the tissue and provide barrier protection.

Further, Dr. Wahls group found that CXCR4 protein was expressed on gingiva, oral mucosa and tonsils, but the expression was strongest in tonsils, particularly in regions where immune surveillance is known to occur. Levels of additional molecules that may bind and entrap HIV, such as complement receptors and FcR, were also higher in the tonsils. However, when antiviral proteins were examined, lower levels of SLPI (secretory leukocyte protease inhibitor), defen
'"/>

Contact: Audra Cox
acox@asip.org
301-634-7409
American Journal of Pathology
26-Jul-2007


Page: 1 2

Related biology news :

1. Strength of connections between brain regions may affect an adolescents response to peer influence
2. UCLA researchers show that culture influences brain cells
3. Fine particulate matter from traffic may influence birth weight
4. TU Delft tracks the influence of a cancer inhibitor on a single DNA molecule
5. Childhood environment influences reproductive function
6. A relative of anti-aging gene Klotho also influences metabolic activity, obesity
7. Spousal choices can influence the risk of developing alcoholism
8. Similar brain chemicals influence aggression in fruit flies and humans
9. Location, location -- Cell sizes, lives influenced by host size
10. Folate and B12 may influence cognition in seniors
11. Evolutionary influences on proteins

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Can the tonsils influence oral HIV transmission

(Date:7/23/2014)... Chrysomya megacephala is commonly found in dead bodies ... time of death, referred to as the post mortem ... C. megacephala from Tamil Nadu is provided for ... characterization through generation of DNA barcoding. This study, significant ... Biodiversity Data Journal . , Chrysomya megacephala ...
(Date:7/23/2014)... New Rochelle, NY -- The potential for clinical ... for transplant-based therapeutic strategies has previously been hindered ... the development of tumors. The ability to use ... for the treatment of heart disease, specifically acute ... Stem Cells and Development , a peer-reviewed ...
(Date:7/23/2014)... MINNETONKA, Minn. , July 23, 2014 /PRNewswire/ ... technology company specializing in clinical study management systems, ... West , a proven life sciences industry executive ... named Chief Operating Officer (COO).  Clareece will be ... and sales growth, operational efficiency and quality product/service ...
Breaking Biology News(10 mins):Dead body feeding larvae useful in forensic investigations 2MedNet Appoints Clareece West As Chief Operating Officer 2
(Date:7/23/2014)... July 23, 2014 ... of Trendlines Agtech , announced it has ... Israel,s leading agricultural thermoplastics applications companies. ... Valentis,s technology combines nanocrystalline cellulose (NCC), a biodegradable, ... additional nanoparticles to produce highly improved polymeric films. ...
(Date:7/23/2014)... regulated information -- UCB today announced an important advance ... topline results from the latest Phase 3 study ... evaluate the efficacy and safety of brivaracetam ... to placebo, as adjunctive treatment in adult focal ... despite treatment with one or two concomitant antiepileptic ...
(Date:7/23/2014)... 2014  Sofinnova Ventures, a Menlo Park ... of Sofinnova Venture Partners IX, L.P. at the hard ... initial fund target of $425 million. Sofinnova ... Consistent with recent funds, SVP IX will provide capital ... along with select investments in earlier stage opportunities. Investments ...
(Date:7/23/2014)... 2014 OncLive® is pleased to ... joined its Strategic Alliance Partnership program. , ... UNC Lineberger will have the opportunity to work ... its cutting-edge research initiatives, community-directed cancer prevention programs, ... work with OncLive to educate their peers by ...
Breaking Biology Technology:Valentis Nanotech Signs MOU to Integrate Technology in Thermoplastics Production 2Major advance in UCB pipeline: positive topline Phase 3 results for brivaracetam in epilepsy patients with partial-onset seizures 2Major advance in UCB pipeline: positive topline Phase 3 results for brivaracetam in epilepsy patients with partial-onset seizures 3Major advance in UCB pipeline: positive topline Phase 3 results for brivaracetam in epilepsy patients with partial-onset seizures 4Major advance in UCB pipeline: positive topline Phase 3 results for brivaracetam in epilepsy patients with partial-onset seizures 5Major advance in UCB pipeline: positive topline Phase 3 results for brivaracetam in epilepsy patients with partial-onset seizures 6Major advance in UCB pipeline: positive topline Phase 3 results for brivaracetam in epilepsy patients with partial-onset seizures 7Sofinnova Raises $500 Million Biotech Venture Fund 2OncLive Expands Its Strategic Alliance Partnership Program With the Addition of UNC Lineberger Comprehensive Cancer Center 2OncLive Expands Its Strategic Alliance Partnership Program With the Addition of UNC Lineberger Comprehensive Cancer Center 3
Cached News: